NDC 68152-103

Zevalin

Ibritumomab Tiuxetan

Zevalin is a Kit in the Human Prescription Drug category. It is labeled and distributed by Spectrum Pharmaceuticals, Inc.. The primary component is .

• Product ID: 68152-103_2783f9e8-22ed-4efb-9661-bb1ea9aba9aa
• NDC: 68152-103
• Product Type: Human Prescription Drug
• Proprietary Name: Zevalin
• Generic Name: Ibritumomab Tiuxetan
• Dosage Form: Kit
• Marketing Start Date: 2002-02-19
• Marketing Category: BLA / BLA
• Application Number: BLA125019
• Labeler Name: Spectrum Pharmaceuticals, Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 68152-103-03

1 KIT in 1 CARTON (68152-103-03) * 2 mL in 1 VIAL * 2 mL in 1 VIAL * 10 mL in 1 VIAL

• Marketing Start Date: 2002-02-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 68152-103-03 [68152010303]

Zevalin KIT

• Marketing Category: BLA
• Application Number: BLA125019
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2002-02-19

Drug Details

OpenFDA Data

• SPL SET ID: ccf29429-bf8e-4cce-bd12-1de56853fc5b
• Manufacturer:
  • Spectrum Pharmaceuticals, Inc.

NDC Crossover Matching brand name "Zevalin" or generic name "Ibritumomab Tiuxetan"

NDC	Brand Name	Generic Name
68152-103	Zevalin	ibritumomab tiuxetan
72893-007	Zevalin	ibritumomab tiuxetan